Results 111 to 120 of about 21,990 (200)

Redemption for the Field of Oncolytic Virotherapy

open access: yesMolecular Therapy, 2011
The field of targeted and transgene-armed oncolytic viruses has been through a cycle of boom (mid-1990s) and bust (the early 2000s). In January 2011, however, Amgen—the biggest independent biotechnology company in the world—jumped headfirst into the field by acquiring Biovex for $425 million and promising potential success-based milestone payments of ...
openaire   +2 more sources

Integrating Oncolytic Virus Engineering and Delivery Strategies for Enhanced Cancer Virotherapy

open access: yesAggregate
Oncolytic virotherapy represents a compelling strategy for cancer immunotherapy, integrating direct tumor cell lysis with the activation of systemic antitumor immunity.
Jiliang Zhao   +5 more
doaj   +1 more source

Analisa Kestabilan Model Matematika untuk Penyembuhan Kanker Menggunakan Oncolytic Virotherapy [PDF]

open access: yes, 2016
. Oncolytic virotherapy is one type of cancer treatment using oncolytic virus. In this paper, we will present a mathematical model for treatment of cancer using oncolytic virotherapy with the burst size of a virus (the number of new viruses released ...
Via Novellina, Via Novellina
core  

Enhancing oncolytic virotherapy with a tri-specific T-cell engager targeting CD3ε, EpCaM, and 4-1BB: preclinical evaluation and implications for cancer immunotherapy

open access: yesBMC Medicine
Background Cytotoxic T-cell-mediated tumor lysis is a key mechanism of oncolytic virotherapy. While oncolytic viruses expressing bispecific T-cell engagers (BiTE) enhance tumor targeting, they lack costimulatory signals, leading to T-cell exhaustion.
Zhongyi Dong   +11 more
doaj   +1 more source

Celyvir: Oncolytic Virotherapy with Mesenchymal Stromal Cells. From Concept to Clinical Translation

open access: yes
Oncolytic virotherapy harnesses genetically engineered viruses to selectively infect and lyse tumor cells while stimulating antitumor immunity through pro-inflammatory microenvironment activation.
Alvaro Morales-Molina   +1 more
core   +1 more source

The emerging role of oncolytic virotherapy in genitourinary malignancies. [PDF]

open access: yesFront Cell Dev Biol
Baboghlian J   +7 more
europepmc   +1 more source

Home - About - Disclaimer - Privacy